Arcutis Biotherapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC ARQT

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

1,014,826

Value ($000)

29,471

Weight

0.0%

2020 Q1 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	29,471	0.0%	1,014,826	12/31/2025
2025 Q3	11/10/2025	18,839	0.0%	999,434	9/30/2025
2025 Q2	8/12/2025	13,530	0.0%	965,066	6/30/2025
2025 Q1	9/15/2025	13,462	0.0%	860,768	3/31/2025
2024 Q4	2/6/2025	12,242	0.0%	878,804	12/31/2024
2024 Q3	11/12/2024	7,997	0.0%	859,846	9/30/2024
2024 Q2	8/12/2024	7,917	0.0%	851,324	6/30/2024
2024 Q1	5/9/2024	7,440	0.0%	750,724	3/31/2024
2023 Q4	2/6/2024	1,845	0.0%	571,318	12/31/2023
2023 Q3	11/8/2023	2,038	0.0%	383,813	9/30/2023
2023 Q2	8/10/2023	3,144	0.0%	329,942	6/30/2023
2023 Q1	5/12/2023	3,328	0.0%	302,502	3/31/2023
2022 Q4	2/13/2023	4,466	0.0%	301,728	12/31/2022
2022 Q3	11/14/2022	5,563	0.0%	291,093	9/30/2022
2022 Q2	8/15/2022	4,630	0.0%	217,260	6/30/2022
2022 Q1	5/13/2022	3,871	0.0%	200,964	3/31/2022
2021 Q4	2/11/2022	4,116	0.0%	198,453	12/31/2021
2021 Q3	11/16/2021	4,679	0.0%	195,837	9/30/2021
2021 Q2	8/16/2021	5,278	0.0%	193,382	6/30/2021
2021 Q1	5/17/2021	5,199	0.0%	179,680	3/31/2021
2020 Q4	2/16/2021	3,979	0.0%	141,439	12/31/2020
2020 Q3	11/13/2020	3,242	0.0%	110,623	9/30/2020
2020 Q2	8/20/2020	2,064	0.0%	68,246	6/30/2020
2020 Q1	5/15/2020	657	0.0%	22,021	3/31/2020